SCHEMBL24965425

SCHEMBL24965425

c1ccc(-c2ccc(N(c3ccccc3-c3ccccc3-c3ccc4ccccc4c3)c3ccccc3-c3cccc4sc5ccccc5c34)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 11/20 0.39
S1PR4 O95977 8/20 0.39
ALOX5 P09917 1/20 0.32
BRDT Q58F21 1/20 0.31
GSTP1 P09211 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
CASP1 P29466 1/20 0.31
HIF1A Q16665 1/20 0.31
HSD17B10 Q99714 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
GPR84 Q9NQS5 1/20 0.31
HDAC4 P56524 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
HSD17B1 P14061 1/20 0.30
HSD17B2 P37059 1/20 0.30
F9 P00740 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23231921 1.00 S1PR5 (0.39) S1PR5S1PR4ALOX5BRDTGSTP1
SCHEMBL24964395 0.97 S1PR5 (0.39) S1PR5S1PR4ALOX5BRDTGSTP1
SCHEMBL24965418 0.97 S1PR5 (0.39) S1PR5S1PR4ALOX5BRDTGSTP1
SCHEMBL24963022 0.96 S1PR5 (0.39) S1PR5S1PR4ALOX5BRDTGSTP1
SCHEMBL24963031 0.96 S1PR5 (0.39) S1PR5S1PR4ALOX5BRDTGSTP1
SCHEMBL23231924 0.94 S1PR5 (0.37) S1PR5S1PR4ALOX5BRDTGSTP1
SCHEMBL24964106 0.94 S1PR5 (0.36) S1PR5S1PR4ALOX5BRDTHSD17B1
SCHEMBL24964099 0.94 S1PR5 (0.36) S1PR5S1PR4ALOX5BRDTHSD17B1
SCHEMBL24965664 0.93 S1PR5 (0.38) S1PR5S1PR4ALOX5BRDTGSTP1
SCHEMBL24965666 0.93 S1PR5 (0.38) S1PR5S1PR4ALOX5BRDTGSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, LEF1, MLX S1PR5 4509/4885S1PR4 3848/4885ALOX5 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.